carbamates has been researched along with clofibrate in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fehér, J; Füst, G; Gerö, S; Horváth, M; Link, E; Szondy, E | 2 |
Caputo, G; Parodi, FA | 1 |
Pola, P | 2 |
Bagliani, A; Borri, P; Parravicini, R | 1 |
Lombardi, M; Riboli, E; Valiensi, M | 1 |
Zdichynec, B | 1 |
Bellotti, L; Frigo, G | 1 |
2 trial(s) available for carbamates and clofibrate
Article | Year |
---|---|
[The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Topics: Adult; Aged; Arteriosclerosis; Carbamates; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Synergism; Female; Humans; Male; Middle Aged; Pyridinolcarbamate | 1975 |
[The importance of pyridinolcarbamate and clofibrate association in the treatment of arteriosclerosis].
Topics: Adult; Aged; Arteriosclerosis; Carbamates; Clinical Trials as Topic; Clofibrate; Drug Evaluation; Drug Synergism; Female; Humans; Male; Middle Aged; Pyridinolcarbamate | 1975 |
7 other study(ies) available for carbamates and clofibrate
Article | Year |
---|---|
[The effect of clofibrate (Miscleron) and pyridinol carbamate (Prodectin) on immunologic factors in experimental arteriosclerosis].
Topics: Animals; Antigen-Antibody Complex; Arteriosclerosis; Carbamates; Cell Migration Inhibition; Cholesterol, Dietary; Clofibrate; Diet, Atherogenic; Pyridinolcarbamate; Rabbits | 1979 |
The effect of clofibrate and pyridinol carbamate on the circulating immune complexes and cellular immune response in experimental atherosclerosis.
Topics: Animals; Antigen-Antibody Complex; Arteriosclerosis; Carbamates; Cell Migration Inhibition; Cholesterol; Clofibrate; Complement Inactivator Proteins; Immunity, Cellular; Male; Pyridinolcarbamate; Rabbits; Time Factors; Triglycerides | 1978 |
[The pyridinolcarbamate-clofibrate combination in the treatment of vascular diseases in diabetics].
Topics: Adult; Aged; Carbamates; Clofibrate; Diabetic Angiopathies; Drug Combinations; Drug Evaluation; Female; Humans; Leg; Male; Middle Aged; Pyridinolcarbamate; Time Factors | 1976 |
[Treatment of arteriosclerotic peripheral chronic obliterating arteriopathies (A.P.C.O.) of the lower extremities with a new pharmacologic combination].
Topics: Adult; Aged; Arteriosclerosis Obliterans; Carbamates; Chronic Disease; Clofibrate; Drug Combinations; Drug Evaluation; Female; Humans; Leg; Male; Middle Aged; Pyridinolcarbamate | 1975 |
[Therapeutic results with combination of pyridinolcarbamate and clofibrate in atherosclerotic patients].
Topics: Adult; Aged; Arteriosclerosis; Carbamates; Clofibrate; Coronary Disease; Drug Combinations; Female; Humans; Intermittent Claudication; Male; Middle Aged; Pyridinolcarbamate | 1976 |
[Editorial: Prevention and therapy of arteriosclerosis in USSR].
Topics: Arteriosclerosis; Carbamates; Cholestyramine Resin; Clofibrate; Humans; Nicotinic Acids; USSR | 1973 |
[Quantitative simultaneous determination with HPLC of clofibrate and pyridinolcarbamate].
Topics: Carbamates; Chromatography, High Pressure Liquid; Clofibrate; Pyridinolcarbamate | 1983 |